A possible pill mix-up has prompted Pfizer to recall more than two dozen lots of a prescription contraceptive drug, the drug maker said.

CVS/pharmacy has introduced a program that allows pharmacy patients to receive immediate notification via text message when their prescription is ready to be picked up, the drug store chain said.

Self-monitoring blood glucose levels in Type 2 diabetics not on an insulin regimen may contribute little to managing the disease, according to an analysis published online last month by The Cochran Library.

As many as 111 million Americans had gotten a flu shot by mid-November, representing 36% of the 305 million Americans older than 6 months of age, the Centers for Disease Control and Prevention reported in early December.

Female diabetes patients may experience a greater degree of hearing loss as they get older, particularly if their condition is not well-controlled by medication, according to a new study conducted at Henry Ford Hospital in Detroit.

The Food and Drug Administration has approved a generic drug for anxiety made by Hi-Tech Pharmacal, the drug maker said Tuesday.

The Food and Drug Administration has approved a new treatment for Type 2 diabetes made by Eli Lilly and Boehringer Ingelheim, the drug makers said.

For every dollar spent on over-the-counter medicines, the U.S. healthcare system realizes a savings of between $6 and $7, or $102 billion all told, the Consumer Healthcare Products Association announced Tuesday with the release of this new study, "The Value of OTC Medicine to the United States."

In an effort to strengthen its focus on its corporate-owned Rexall and Rexall/Pharma Plus store network, Katz Group Canada has signed a definitive agreement to sell its banner pharmacy business, Drug Trading, and its franchise pharmacy business, Medicine Shoppe Canada, to McKesson for about CAD $920 million in cash.

The charitable arm of the National Association of Chain Drug Stores has announced the 2011 recipients of its pharmacy student scholarship awards.

A goal to standardize risk evaluation and mitigation strategies and modernize the U.S. drug safety system in a proposed reauthorization of the Prescription Drug User Fee Act has drawn support from the country's main chain retail pharmacy lobby.